These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30763540)

  • 1. The Genetic Influence on Corticosteroid-Induced Ocular Hypertension: A Field Positioned for Discovery.
    Chan W; Wiggs JL; Sobrin L
    Am J Ophthalmol; 2019 Jun; 202():1-5. PubMed ID: 30763540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature.
    Jones R; Rhee DJ
    Curr Opin Ophthalmol; 2006 Apr; 17(2):163-7. PubMed ID: 16552251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyses of Sequence Variants in the MYOC Gene and of Single Nucleotide Polymorphisms in the NR3C1 and FKBP5 Genes in Corticosteroid-Induced Ocular Hypertension.
    Hogewind BF; Micheal S; Schoenmaker-Koller FE; Hoyng CB; den Hollander AI
    Ophthalmic Genet; 2015; 36(4):299-302. PubMed ID: 24417561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Steroid induced ocular hypertension and glaucoma].
    Călugăru D; Călugăru M
    Oftalmologia; 2009; 53(3):15-33. PubMed ID: 19899544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
    Sallam A; Sheth HG; Habot-Wilner Z; Lightman S
    Am J Ophthalmol; 2009 Aug; 148(2):207-213.e1. PubMed ID: 19403113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtenon's depot corticosteroid injections in patients with a history of corticosteroid-induced intraocular pressure elevation.
    Levin DS; Han DP; Dev S; Wirostko WJ; Mieler WF; Connor TB; George V; Eastwood D
    Am J Ophthalmol; 2002 Feb; 133(2):196-202. PubMed ID: 11812422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid-induced glaucoma.
    Urban RC; Dreyer EB
    Int Ophthalmol Clin; 1993; 33(2):135-9. PubMed ID: 8325728
    [No Abstract]   [Full Text] [Related]  

  • 8. Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.
    Fini ME; Schwartz SG; Gao X; Jeong S; Patel N; Itakura T; Price MO; Price FW; Varma R; Stamer WD
    Prog Retin Eye Res; 2017 Jan; 56():58-83. PubMed ID: 27666015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe intraocular pressure response to periocular or intravitreal steroid treatment in Australia and New Zealand: data from the Australian and New Zealand Ophthalmic Surveillance Unit.
    Fitzgerald JT; Saunders L; Ridge B; White AJ; Goldberg I; Clark B; Mills RA; Craig JE
    Clin Exp Ophthalmol; 2015 Apr; 43(3):234-8. PubMed ID: 25214011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma.
    Wordinger RJ; Clark AF
    Prog Retin Eye Res; 1999 Sep; 18(5):629-67. PubMed ID: 10438153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular pressure profile of a child on a systemic corticosteroid.
    Tham CC; Ng JS; Li RT; Chik KW; Lam DS
    Am J Ophthalmol; 2004 Jan; 137(1):198-201. PubMed ID: 14700676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension.
    Fingert JH; Clark AF; Craig JE; Alward WL; Snibson GR; McLaughlin M; Tuttle L; Mackey DA; Sheffield VC; Stone EM
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):145-52. PubMed ID: 11133859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids.
    Garbe E; LeLorier J; Boivin JF; Suissa S
    Lancet; 1997 Oct; 350(9083):979-82. PubMed ID: 9329512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid-induced ocular hypertension in normal cattle.
    Gerometta R; Podos SM; Candia OA; Wu B; Malgor LA; Mittag T; Danias J
    Arch Ophthalmol; 2004 Oct; 122(10):1492-7. PubMed ID: 15477461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of single nucleotide polymorphisms in the SFRS3 and FKBP4 genes in corticosteroid-induced ocular hypertension.
    Hogewind BF; Micheal S; Bakker B; Hoyng CB; den Hollander AI
    Ophthalmic Genet; 2012 Dec; 33(4):221-4. PubMed ID: 22921020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical analysis of corticosteroid ocular hypertension and corticosteroid glaucoma after photorefractive keratectomy].
    Li C; Zhang J; Huang C
    Zhonghua Yan Ke Za Zhi; 1999 May; 35(3):179-82. PubMed ID: 11835800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
    Nazm N; Dubey S; Gandhi M; Pegu J
    Am J Ophthalmol; 2010 Mar; 149(3):525-6; author reply 526-7. PubMed ID: 20172078
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucocorticoid therapy and ocular hypertension.
    Dibas A; Yorio T
    Eur J Pharmacol; 2016 Sep; 787():57-71. PubMed ID: 27388141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.
    Parekh A; Srivastava S; Bena J; Albini T; Nguyen QD; Goldstein DA
    JAMA Ophthalmol; 2015 May; 133(5):568-73. PubMed ID: 25719937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased intraocular pressure with corticosteroid medication after photorefractive keratectomy.
    Levy Y; Nemet P
    Surv Ophthalmol; 1996; 41(2):187-8. PubMed ID: 8890449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.